Largest biotech by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 24 biotech ranked by earnings, at TRY 429.2B, ahead of Amgen (TRY 388.9B) and Biogen (TRY 65.2B). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesTRY 429.2B
- Median
- -TRY 3.5B
- Combined market value
- TRY 42.46T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | TRY 429.2B | TRY 10.58T | TRY 8,529.36 | 0.68% down | 33% up | ||
| 2 | AmgenAMGN · Health Care | TRY 388.9B | TRY 12.26T | TRY 22,670.31 | 1.85% down | 34% up | ||
| 3 | BiogenBIIB · Health Care | TRY 65.2B | TRY 1.87T | TRY 12,636.93 | 0.10% down | 49% up | ||
| 4 | argenxARGX · Health Care | TRY 65.2B | TRY 3.04T | TRY 48,303.29 | 1.07% up | 4% up | ||
| 5 | ExelixisEXEL · Health Care | TRY 39.5B | TRY 843.8B | TRY 3,457.94 | 0.09% up | 63% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | TRY 24.1B | TRY 840.9B | TRY 8,307.94 | 0.72% down | 20% up | ||
| 7 | QiagenQGEN · Health Care | TRY 21.4B | TRY 517.5B | TRY 2,505.95 | 0.13% down | 12% up | ||
| 8 | Halozyme TherapeuticsHALO · Health Care | TRY 16B | TRY 551.1B | TRY 4,834.11 | 0.13% down | 37% up | ||
| 9 | Krystal BiotechKRYS · Health Care | TRY 10.3B | TRY 453B | TRY 15,286.63 | 1.52% up | 46% up | ||
| 10 | Bio-TechneTECH · Health Care | TRY 9.2B | TRY 576.3B | TRY 3,668.27 | 0.14% up | 26% up | ||
| 11 | RepligenRGEN · Health Care | TRY 2.5B | TRY 549B | TRY 8,588.62 | 5.00% up | 5% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | -TRY 3B | TRY 231.8B | TRY 1,431.90 | 0.35% down | 88% up | ||
| 13 | Twist BioscienceTWST · Health Care | -TRY 3.9B | TRY 389.7B | TRY 5,716.50 | 1.20% up | 340% up | ||
| 14 | CG OncologyCGON · Health Care | -TRY 8.1B | TRY 351.6B | TRY 3,936.84 | 1.12% down | 85% up | ||
| 15 | Kodiak SciencesKOD · Health Care | -TRY 11.6B | TRY 318B | TRY 4,862.10 | 0.41% down | 396% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | -TRY 15.7B | TRY 524.5B | TRY 6,144.21 | 0.25% up | 87% up | ||
| 17 | ImmunityBioIBRX · Health Care | -TRY 17.7B | TRY 330B | TRY 310.19 | 1.76% down | 193% up | ||
| 18 | Scholar Rock HoldingSRRK · Health Care | -TRY 19.1B | TRY 289.7B | TRY 2,374.31 | 4.43% up | 14% up | ||
| 19 | ImmunovantIMVT · Health Care | -TRY 25.5B | TRY 347.9B | TRY 1,681.31 | 0.38% up | 43% up | ||
| 20 | CRISPR TherapeuticsCRSP · Health Care | -TRY 29.3B | TRY 202.4B | TRY 2,087.07 | 3.06% up | 21% down | ||
| 21 | VaxcytePCVX · Health Care | -TRY 38.7B | TRY 469.1B | TRY 2,963.16 | 1.09% down | 22% up | ||
| 22 | Revolution MedicinesRVMD · Health Care | -TRY 57.1B | TRY 1.73T | TRY 7,999.02 | 2.52% down | 131% up | ||
| 23 | BioNTechBNTX · Health Care | -TRY 63.6B | TRY 1.06T | TRY 4,271.49 | 0.20% down | 16% down | ||
| 24 | ModernaMRNA · Health Care | -TRY 142.3B | TRY 4.13T | TRY 10,213.70 | 2.08% down | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4368 TRY).
Questions and answers
Which biotech rank first by earnings?
Gilead Sciences (TRY 429.2B), Amgen (TRY 388.9B) and Biogen (TRY 65.2B) are the top three of the 24 biotech ranked by earnings as of 18 Nov 2026, 14:51 UTC.
How many biotech are in this ranking?
24 are ranked by earnings.
What are these biotech worth together?
The 24 biotech ranked by earnings have a combined market value of TRY 42.46T as of 18 Nov 2026, 14:51 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.